Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000086

Chief Medical Officer sold 417 shares at $27.55 ($11,488)

  • Chief Medical Officer acquired 417 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-05-18 Option exercise 10b5-1 +417 $15.44 $6,438 63,860 D
Rodman David Malcom Chief Medical Officer 2026-05-18 Sale 10b5-1 −417 $27.55 $11,488 63,443 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-05-18 Option exercise · Stock Option 10b5-1 −417 4,167 D
Open-market sales · 417 sh · avg $27.55 · $11,488
Loading xslF345X06/wk-form4_1779232505.xml…